BIOMAT Database Logo BIOMAT Database Logo

Insulin and Glucagon: Partners for Life. 2017

Jens Juul Holst, and William Holland, and Jesper Gromada, and Young Lee, and Roger H Unger, and Hai Yan, and Kyle W Sloop, and Timothy J Kieffer, and Nicolas Damond, and Pedro L Herrera
Novo Nordisk Foundation Center for Basic Metabolic Research and Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark.

In August 2016, several leaders in glucagon biology gathered for the European Association for the Study of Diabetes Hagedorn Workshop in Oxford, England. A key point of discussion focused on the need for basal insulin to allow for the therapeutic benefit of glucagon blockade in the treatment of diabetes. Among the most enlightening experimental results presented were findings from studies in which glucagon receptor-deficient mice were administered streptozotocin to destroy pancreatic β cells or had undergone diphtheria toxin-induced β cell ablation. This article summarizes key features of the discussion as a consensus was reached. Agents that antagonize glucagon may be of great benefit for the treatment of diabetes; however, sufficient levels of basal insulin are required for their therapeutic efficacy.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Jens Juul Holst, and William Holland, and Jesper Gromada, and Young Lee, and Roger H Unger, and Hai Yan, and Kyle W Sloop, and Timothy J Kieffer, and Nicolas Damond, and Pedro L Herrera
Systems of life. Pancreas: insulin and glucagon.
January 1996, Nursing times,
Jens Juul Holst, and William Holland, and Jesper Gromada, and Young Lee, and Roger H Unger, and Hai Yan, and Kyle W Sloop, and Timothy J Kieffer, and Nicolas Damond, and Pedro L Herrera
Partners for life.
May 2016, eLife,
Jens Juul Holst, and William Holland, and Jesper Gromada, and Young Lee, and Roger H Unger, and Hai Yan, and Kyle W Sloop, and Timothy J Kieffer, and Nicolas Damond, and Pedro L Herrera
Life partners.
November 2019, Science (New York, N.Y.),
Jens Juul Holst, and William Holland, and Jesper Gromada, and Young Lee, and Roger H Unger, and Hai Yan, and Kyle W Sloop, and Timothy J Kieffer, and Nicolas Damond, and Pedro L Herrera
A combined radioimmunoassay for glucagon and insulin.
October 1975, Diabetologia,
Jens Juul Holst, and William Holland, and Jesper Gromada, and Young Lee, and Roger H Unger, and Hai Yan, and Kyle W Sloop, and Timothy J Kieffer, and Nicolas Damond, and Pedro L Herrera
Insulin and glucagon therapy for alcoholic hepatitis.
June 1981, Gastroenterology,
Jens Juul Holst, and William Holland, and Jesper Gromada, and Young Lee, and Roger H Unger, and Hai Yan, and Kyle W Sloop, and Timothy J Kieffer, and Nicolas Damond, and Pedro L Herrera
Insulin secretion and glucagon.
November 1965, Lancet (London, England),
Jens Juul Holst, and William Holland, and Jesper Gromada, and Young Lee, and Roger H Unger, and Hai Yan, and Kyle W Sloop, and Timothy J Kieffer, and Nicolas Damond, and Pedro L Herrera
Glucagon, glucose, and insulin.
January 1969, JAMA,
Jens Juul Holst, and William Holland, and Jesper Gromada, and Young Lee, and Roger H Unger, and Hai Yan, and Kyle W Sloop, and Timothy J Kieffer, and Nicolas Damond, and Pedro L Herrera
Glucagon and insulin hypoglycaemia.
October 1984, Diabetologia,
Jens Juul Holst, and William Holland, and Jesper Gromada, and Young Lee, and Roger H Unger, and Hai Yan, and Kyle W Sloop, and Timothy J Kieffer, and Nicolas Damond, and Pedro L Herrera
Insulin-glucagon ratio.
March 1972, Israel journal of medical sciences,
Jens Juul Holst, and William Holland, and Jesper Gromada, and Young Lee, and Roger H Unger, and Hai Yan, and Kyle W Sloop, and Timothy J Kieffer, and Nicolas Damond, and Pedro L Herrera
Insulin glucagon ration.
January 1971, Transactions of the Association of American Physicians,
Copied contents to your clipboard!